Belite Bio (BLTE) Shares Outstanding (2020 - 2026)
Belite Bio (BLTE) posted quarterly Shares Outstanding (Entity) of $680.0 for Q1 2026, down 100.0% year-over-year from $32.1 million in Q1 2025, and down 100.0% quarter-over-quarter from $33.5 million in Q4 2025.
Belite Bio (BLTE) Shares Outstanding (2020 - 2026) Analysis & Trends
Belite Bio's Shares Outstanding (Entity) history runs 7 years deep, the most recent figure standing at $680.0 for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) fell 100.0% year-over-year to $680.0; the TTM figure through Mar 2026 stood at $680.0 (down 100.0% YoY), while the FY2025 annual figure was $33.5 million, up 9.82% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $680.0, down from $33.5 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $33.5 million in Q4 2025, with the low at $680.0 in Q1 2026.
- The 5-year median for Shares Outstanding (Entity) is $28.5 million (2023), against an average of $25.8 million.
- The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Entity) soared 108.74% in 2022, then tumbled 100.0% in 2026.
- Belite Bio's Shares Outstanding (Entity) stood at $20.0 million in 2022, then soared by 33.12% to $26.6 million in 2023, then rose by 14.83% to $30.5 million in 2024, then climbed by 9.82% to $33.5 million in 2025, then sank by 100.0% to $680.0 in 2026.
- Business Quant data shows BLTE's Shares Outstanding (Entity) at $680.0 in Q1 2026, $33.5 million in Q4 2025, and $32.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Belite Bio | 6.40 Bn | 6.40 Bn | - | 33.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 680.00 |
| Dec 31, 2025 | 33.54 Mn |
| Sep 30, 2025 | 32.63 Mn |
| Jun 30, 2025 | 32.59 Mn |
| Mar 31, 2025 | 32.08 Mn |
| Dec 31, 2024 | 30.54 Mn |
| Sep 30, 2024 | 30.23 Mn |
| Jun 30, 2024 | 30.32 Mn |
| Mar 31, 2024 | 29.68 Mn |
| Dec 31, 2023 | 26.59 Mn |
| Sep 30, 2023 | 27.32 Mn |
| Jun 30, 2023 | 25.79 Mn |
| Mar 31, 2023 | 20.95 Mn |
| Dec 31, 2022 | 19.98 Mn |
| Sep 30, 2022 | 24.87 Mn |
| Jun 30, 2022 | 14.99 Mn |
| Dec 31, 2021 | 9.57 Mn |
| Dec 31, 2020 | 8.79 Mn |